SK286819B6 - Izolovaný polynukleotid, izolovaný C5-epimerázový polypeptid, spôsob produkcie proteínu a spôsob zvýšenia aktivity C5-epimerázy - Google Patents

Izolovaný polynukleotid, izolovaný C5-epimerázový polypeptid, spôsob produkcie proteínu a spôsob zvýšenia aktivity C5-epimerázy Download PDF

Info

Publication number
SK286819B6
SK286819B6 SK859-2003A SK8592003A SK286819B6 SK 286819 B6 SK286819 B6 SK 286819B6 SK 8592003 A SK8592003 A SK 8592003A SK 286819 B6 SK286819 B6 SK 286819B6
Authority
SK
Slovakia
Prior art keywords
polynucleotide
epimerase
sequence
polypeptide
protein
Prior art date
Application number
SK859-2003A
Other languages
English (en)
Slovak (sk)
Other versions
SK8592003A3 (en
Inventor
Markku Jalkanen
Darwish Kamel El
Ulf Lindahl
Jin-Ping Li
Original Assignee
Biotie Therapies Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biotie Therapies Corporation filed Critical Biotie Therapies Corporation
Publication of SK8592003A3 publication Critical patent/SK8592003A3/sk
Publication of SK286819B6 publication Critical patent/SK286819B6/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/90—Isomerases (5.)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y501/00—Racemaces and epimerases (5.1)
    • C12Y501/03—Racemaces and epimerases (5.1) acting on carbohydrates and derivatives (5.1.3)
    • C12Y501/03012—UDP-glucuronate 5'-epimerase (5.1.3.12)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Position Input By Displaying (AREA)
  • Chemical Or Physical Treatment Of Fibers (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
SK859-2003A 2000-12-08 2001-12-07 Izolovaný polynukleotid, izolovaný C5-epimerázový polypeptid, spôsob produkcie proteínu a spôsob zvýšenia aktivity C5-epimerázy SK286819B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30418000P 2000-12-08 2000-12-08
PCT/FI2001/001068 WO2002046379A2 (en) 2000-12-08 2001-12-07 Glucuronyl c5-epimerase, dna encoding the same and uses thereof

Publications (2)

Publication Number Publication Date
SK8592003A3 SK8592003A3 (en) 2004-03-02
SK286819B6 true SK286819B6 (sk) 2009-06-05

Family

ID=23175421

Family Applications (1)

Application Number Title Priority Date Filing Date
SK859-2003A SK286819B6 (sk) 2000-12-08 2001-12-07 Izolovaný polynukleotid, izolovaný C5-epimerázový polypeptid, spôsob produkcie proteínu a spôsob zvýšenia aktivity C5-epimerázy

Country Status (18)

Country Link
US (3) US6887698B2 (de)
EP (1) EP1379639B1 (de)
JP (1) JP2004515239A (de)
AT (1) ATE301185T1 (de)
AU (2) AU1717402A (de)
BG (1) BG107975A (de)
CA (1) CA2436728A1 (de)
CZ (1) CZ303693B6 (de)
DE (1) DE60112476T2 (de)
DK (1) DK1379639T3 (de)
EE (1) EE05296B1 (de)
ES (1) ES2245707T3 (de)
HK (1) HK1060147A1 (de)
HU (1) HUP0500099A3 (de)
PT (1) PT1379639E (de)
SK (1) SK286819B6 (de)
WO (1) WO2002046379A2 (de)
ZA (1) ZA200304136B (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102012016127A1 (de) 2011-08-31 2013-02-28 Daniel Elias Bioaktive, regenerative Mischung zur Herstellung eines Ergänzungsnahrungsmittels

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7120162B1 (en) * 2000-08-03 2006-10-10 Skyworks Solutions, Inc. System and method for processing audio and video data in a wireless handset
US6887698B2 (en) * 2000-12-08 2005-05-03 Biotie Therapies Corp. Glucuronyl C5-epimerase, DNA encoding the same and uses thereof
WO2011110683A2 (en) * 2010-03-12 2011-09-15 Glyconova Srl Glce as a target for anti-tumour therapy
US9896708B2 (en) 2013-06-12 2018-02-20 Seikagaku Corporation Heparosan-glucuronic acid-5-epimerase, and method for producing polysaccharide using same
WO2018135027A1 (ja) 2017-01-19 2018-07-26 味の素株式会社 ヘキスロン酸残基が異性化されたヘパロサン化合物の製造方法
WO2019050051A1 (en) 2017-09-05 2019-03-14 Ajinomoto Co., Inc. MUTANT OF 2-O-SULFATION ENZYME AND MUTANT OF 3-O-SULFATION ENZYME, AND METHOD OF USE

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9221163D0 (en) * 1992-10-08 1992-11-25 Nobipol And Protan Biopolymer Dna compounds
IT1271057B (it) 1994-11-04 1997-05-26 Inalco Spa Polisaccaridi aventi un elevato contenuto di acido iduronico
SE9701454D0 (sv) * 1997-04-18 1997-04-18 Ulf Lindahl new DNA sequences and a process for enzyme manufacture
GB9710991D0 (en) * 1997-05-28 1997-07-23 Danisco Enzyme
US7244601B2 (en) * 1997-12-15 2007-07-17 National Research Council Of Canada Fusion proteins for use in enzymatic synthesis of oligosaccharides
JP2001145488A (ja) * 1999-11-19 2001-05-29 Natl Inst Of Advanced Industrial Science & Technology Meti シロイヌナズナ由来のｇｄｐ−４−ケト−６−デオキシ−ｄ−マンノース−３，５−エピメラーゼ−４−レダクターゼ遺伝子
US6887698B2 (en) * 2000-12-08 2005-05-03 Biotie Therapies Corp. Glucuronyl C5-epimerase, DNA encoding the same and uses thereof

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102012016127A1 (de) 2011-08-31 2013-02-28 Daniel Elias Bioaktive, regenerative Mischung zur Herstellung eines Ergänzungsnahrungsmittels
DE202012012998U1 (de) 2011-08-31 2014-06-13 Daniel Elias Bioaktive, regenerative Mischung zur Herstellung eines Ergänzungsnahrungsmittels

Also Published As

Publication number Publication date
HUP0500099A2 (hu) 2005-05-30
DE60112476D1 (de) 2005-09-08
US20100261253A1 (en) 2010-10-14
AU2002217174B2 (en) 2006-06-22
ZA200304136B (en) 2004-05-04
WO2002046379A2 (en) 2002-06-13
HUP0500099A3 (en) 2010-03-29
SK8592003A3 (en) 2004-03-02
EE05296B1 (et) 2010-04-15
US20020127696A1 (en) 2002-09-12
ES2245707T3 (es) 2006-01-16
CA2436728A1 (en) 2002-06-13
EE200300265A (et) 2003-10-15
ATE301185T1 (de) 2005-08-15
PT1379639E (pt) 2005-10-31
US6887698B2 (en) 2005-05-03
WO2002046379A3 (en) 2003-11-06
JP2004515239A (ja) 2004-05-27
EP1379639B1 (de) 2005-08-03
CZ303693B6 (cs) 2013-03-20
BG107975A (bg) 2004-11-30
DE60112476T2 (de) 2006-06-29
US20050181434A1 (en) 2005-08-18
US7399626B2 (en) 2008-07-15
HK1060147A1 (en) 2004-07-30
AU1717402A (en) 2002-06-18
CZ20031809A3 (cs) 2004-01-14
EP1379639A2 (de) 2004-01-14
DK1379639T3 (da) 2005-11-28

Similar Documents

Publication Publication Date Title
US20100261253A1 (en) Glucuronyl C5-Epimerase, DNA encoding the same and uses thereof
WO1998050424A2 (en) Human serine protease precursor
Daniele et al. Biochemical characterization of arylsulfatase E and functional analysis of mutations found in patients with X-linked chondrodysplasia punctata
US6861254B1 (en) Heparan sulfate D-glucosaminyl 3-O-sulfotransferases, and uses therefor
US5925521A (en) Human serine carboxypeptidase
US6083700A (en) Human goose-type lysozyme
AU2002217174A1 (en) Glucuronyl C5-epimerase, DNA encoding the same and uses thereof
US20030166136A1 (en) Human C-type lectin
WO1999022005A2 (en) Heparan sulfate d-glucosaminyl 3-o-sulfotransferases, an uses therefor
WO2004099402A1 (en) Glycosylation variants of bace
US5858750A (en) Human retinol dehydrogenase type II homolog
US5985638A (en) Microsomal signal peptidase subunit
US5840534A (en) Human SMT3-like protein
US20030108993A1 (en) Human mitochondrial chaperone protein
WO2000011164A1 (en) Human angiopoietin-3
US6037163A (en) Human microfibril-associated glycoprotein 4 splice variant
US5834241A (en) Vesicle trafficking protein
CA2333467A1 (en) Human presenilin-associated protein
US5916764A (en) Human phosphatidylinositol synthase
US6074843A (en) Polynucleotides encoding human TSC-22 protein homologs
US7273724B1 (en) Polypeptide-human actin-binding protein 54 and a polynucleotide encoding the same
US20030113844A1 (en) Delayed rectifier potassium channel subunit
US20040091861A1 (en) Novel polypeptide-human shc protein 43 and polynucleotide encoding it
CA2341308A1 (en) Human latent transforming growth factor-.beta. binding protein 3
WO1998036069A1 (en) Novel human mago nashi protein

Legal Events

Date Code Title Description
MM4A Patent lapsed due to non-payment of maintenance fees

Effective date: 20101207